Covaxin has 77.3% efficacy: Phase 3 trials data

Newsbred Staff

22nd June 2021
Bharat Biotech have announced that the indigenously developed Covid-19 vaccine Covaxin has showed a 77.3 per cent efficacy in its phase 3 trials.

India has done most vaccination after US, says Dr Harsh Vardhan

Newsbred Staff

8th June 2021
Union Health Minister Harsh Vardhan on Monday informed that India is the second quickest country to vaccinate 23 crore people in 141 days just after the United States...

2021 Newsbred© All Rights Reserved.

Support Us X

Contribute to see NewsBred grow. And rejoice that your input has made it possible.

Contribute to see NewsBred grow.X